iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in iSpecimen Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +1 vs. Q1 2022
- Shares held
- 372.8K
- +62.1K (+20.0%) vs. Q1 2022
- Total value
- $813.0K
- −$1.17M (−58.9%) vs. Q1 2022
- New holders
- 3
- 6 more added
- Sold out
- 2
- 2 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ISPC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $152.0K |
| Q1 2026 | 12 | $83.5K |
| Q4 2025 | 11 | $32.9K |
| Q3 2025 | 12 | $443.0K |
| Q2 2025 | 9 | $66.1K |
| Q1 2025 | 8 | $63.7K |
| Q4 2024 | 7 | $94.9K |
| Q3 2024 | 6 | $182.9K |
| Q2 2024 | 13 | $103.1K |
| Q1 2024 | 11 | $69.1K |
| Q4 2023 | 14 | $195.7K |
| Q3 2023 | 13 | $238.5K |
| Q2 2023 | 13 | $596.9K |
| Q1 2023 | 14 | $665.4K |
| Q4 2022 | 13 | $653.0K |
| Q3 2022 | 15 | $781.0K |
| Q2 2022 | 14 | $813.0K |
| Q1 2022 | 13 | $1.98M |
| Q4 2021 | 13 | $9.21M |
| Q3 2021 | 9 | $5.35M |
| Q2 2021 | 7 | $8.10M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding iSpecimen Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bleichroeder LP | 65,834 | $144.0K | 0.03% | 00.0% | Unchanged |
| Grimes & Company, Inc. | 62,014 | $135.0K | 0.01% | +27,243+78.3% | Added |
| Vanguard Group Inc | 61,462 | $134.0K | 0.00% | +25,376+70.3% | Added |
| BlackRock Inc. | 56,699 | $124.0K | 0.00% | −14,476−20.3% | Reduced |
| Teton Advisors, Inc. | 40,000 | $87.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 23,339 | $50.0K | 0.00% | +1,743+8.1% | Added |
| Schonfeld Strategic Advisors LLC | 19,800 | $44.0K | 0.00% | −300−1.5% | Reduced |
| Citadel Advisors LLC | 19,799 | $43.0K | 0.00% | +19,799 | New |
| Main Street Financial Solutions, LLC | 10,500 | $23.0K | 0.00% | +10,500 | New |
| Morgan Stanley | 5,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,955 | $11.0K | 0.00% | +1,451+41.4% | Added |
| UBS Group AG | 2,351 | $5.00K | 0.00% | +1,779+311.0% | Added |
| Bank of America Corp | 1,053 | $2.00K | 0.00% | +1,053 | New |
| Wells Fargo & Company | 28 | $0 | 0.00% | +2+7.7% | Added |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,351−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,750−100.0% | Sold out |